Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Paulina Gątarek & Joanna Kałużna-Czaplińska. (2022) Nutritional aspects in Parkinson’s disease. Critical Reviews in Food Science and Nutrition 62:23, pages 6467-6484.
Read now
Read now
Shilan Mozaffari, Shekoufeh Nikfar, Marzieh Daniali & Mohammad Abdollahi. (2020) The pharmacological management of constipation in patients with Parkinson’s disease: a much-needed relief. Expert Opinion on Pharmacotherapy 21:6, pages 701-707.
Read now
Read now
Articles from other publishers (63)
Jovana Drljača, Nataša Milošević, Maja Milanović, Ludovico Abenavoli & Nataša Milić. (2023) When the microbiome helps the brain‐current evidence. CNS Neuroscience & Therapeutics 29:S1, pages 43-58.
Crossref
Crossref
Jing Tao, Yunying An, Lingyun Xu, Yuxin Wang, Chaowei Wang, Puze Li, Min Li, Dong Yan, Mingyong Wang, Genshen Zhong & Minna Wu. (2023) The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol. Food & Function 14:10, pages 4647-4661.
Crossref
Crossref
Sara Hashish & Mohamed Salama. (2023) The Role of an Altered Gut Microbiome in Parkinson’s Disease: A Narrative Review. Applied Microbiology 3:2, pages 429-447.
Crossref
Crossref
Chuanqi Chu, Leilei Yu, Yiwen Li, Hang Guo, Qixiao Zhai, Wei Chen & Fengwei Tian. (2023) Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson's disease. Food & Function 14:8, pages 3406-3422.
Crossref
Crossref
Yun Wang, Wen‐jie Chen, Yi‐yang Han, Xuan Xu, Ai‐xia Yang, Jing Wei, Dao‐jun Hong, Xin Fang & Ting‐tao Chen. (2023)
Neuroprotective effect of engineered
Clostridium
butyricum‐pMTL007‐GLP
‐1 on Parkinson's disease mice models via promoting mitophagy
. Bioengineering & Translational Medicine.
Crossref
Crossref
Jong Mi Park, Sang Chul Lee, Chorom Ham & Yong Wook Kim. (2023) Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials. Gut Pathogens 15:1.
Crossref
Crossref
Nasibeh Ghalandari, Farhad Assarzadegan, Hossein Mahdavi, Elham Jamshidi & Hadi Esmaily. (2023) Evaluating the effectiveness of probiotics in relieving constipation in Parkinson’s disease: A systematic review and meta-analysis. Heliyon 9:3, pages e14312.
Crossref
Crossref
Chin-Hsien Lin, Hsin-Chih Lai & Ming-Shiang Wu. (2023) Gut-oriented disease modifying therapy for Parkinson's disease. Journal of the Formosan Medical Association 122:1, pages 9-18.
Crossref
Crossref
Nardane DÜDÜKÇÜ & Serdal ÖĞÜT. (2022) Psychobiotics and Elderly HealthPsikobiyotikler ve Yaşlı Sağlığı. Psikiyatride Güncel Yaklaşımlar 14:4, pages 469-476.
Crossref
Crossref
Subramanian Thangaleela, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika & Chaiyavat Chaiyasut. (2022) Role of Probiotics and Diet in the Management of Neurological Diseases and Mood States: A Review. Microorganisms 10:11, pages 2268.
Crossref
Crossref
Shao Yin & Fengya Zhu. (2022) Probiotics for constipation in Parkinson’s: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Tiantian Li, Chuanqi Chu, Leilei Yu, Qixiao Zhai, Shunhe Wang, Jianxin Zhao, Hao Zhang, Wei Chen & Fengwei Tian. (2022) Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease. Nutrients 14:21, pages 4678.
Crossref
Crossref
Hamed Mirzaei, Saman Sedighi, Ebrahim Kouchaki, Erfaneh Barati, Ehsan Dadgostar, Michael Aschner & Omid Reza Tamtaji. (2021) Probiotics and the Treatment of Parkinson's Disease: An Update. Cellular and Molecular Neurobiology 42:8, pages 2449-2457.
Crossref
Crossref
Diana Filipa Silva, Nuno Empadinhas, Sandra Morais Cardoso & Ana Raquel Esteves. (2022) Neurodegenerative Microbially-Shaped Diseases: Oxidative Stress Meets Neuroinflammation. Antioxidants 11:11, pages 2141.
Crossref
Crossref
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, Elisa Pierella, Marcello Romeo, Giovanni Ricevuti, Marchesi Nicoletta, Salvatore Chirumbolo & Alessia Pascale. (2022) The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment. International Journal of Molecular Sciences 23:20, pages 12289.
Crossref
Crossref
Yitong Du, Yue Li, Xiaojiao Xu, Rongxue Li, Mingkai Zhang, Ying Cui, Liyan Zhang, Zheng Wei, Shiya Wang & Houzhen Tuo. (2022) Probiotics for constipation and gut microbiota in Parkinson's disease. Parkinsonism & Related Disorders 103, pages 92-97.
Crossref
Crossref
Sujith Pavan, Arvind N. Prabhu, Sankar Prasad Gorthi, Bhabatosh Das, Ankur Mutreja, Vignesh Shetty, Thandavarayan Ramamurthy & Mamatha Ballal. (2022) Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease. Folia Microbiologica 67:5, pages 693-706.
Crossref
Crossref
Manuele Biazzo, Manuela Allegra & Gabriele Deidda. (2022) Clostridioides difficile and neurological disorders: New perspectives. Frontiers in Neuroscience 16.
Crossref
Crossref
Chien-Tai Hong, Jia-Hung Chen & Tsai-Wei Huang. (2022) Probiotics treatment for Parkinson disease: a systematic review and meta-analysis of clinical trials. Aging 14:17, pages 7014-7025.
Crossref
Crossref
Jonah Gordon, Gavin Lockard, Molly Monsour, Adam Alayli, Hassan Choudhary & Cesario V. Borlongan. (2022) Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy. International Journal of Molecular Sciences 23:17, pages 10138.
Crossref
Crossref
Parvin Oroojzadeh, Saber Yari Bostanabad & Hajie Lotfi. (2022) Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders. Journal of Molecular Neuroscience 72:9, pages 1952-1964.
Crossref
Crossref
Maciej Chichlowski, Jack Cotter, Neil Fawkes & Neeraj Pandey. (2022) Feed your microbiome and improve sleep, stress resilience, and cognition. Exploration of Medicine, pages 331-344.
Crossref
Crossref
Subramanian Thangaleela, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Muruganantham Bharathi & Chaiyavat Chaiyasut. (2022) Role of the Gut–Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson’s Disease. Microorganisms 10:8, pages 1544.
Crossref
Crossref
Krzysztof Skowron, Anna Budzyńska, Natalia Wiktorczyk-Kapischke, Karolina Chomacka, Katarzyna Grudlewska-Buda, Monika Wilk, Ewa Wałecka-Zacharska, Małgorzata Andrzejewska & Eugenia Gospodarek-Komkowska. (2022) The Role of Psychobiotics in Supporting the Treatment of Disturbances in the Functioning of the Nervous System—A Systematic Review. International Journal of Molecular Sciences 23:14, pages 7820.
Crossref
Crossref
Sujith Pavan, Arvind N Prabhu, Sankar Prasad Gorthi, Vignesh Shetty, Vidya Rajesh, Asha Hegde & Mamatha Ballal. (2022) Dietary interventions in Parkinson’s disease: An update. Biomedicine 42:3, pages 422-426.
Crossref
Crossref
Manlian Zhu, Xia Liu, Yiru Ye, Xiumei Yan, Yiwen Cheng, Longyou Zhao, Feng Chen & Zongxin Ling. (2022) Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease. Frontiers in Immunology 13.
Crossref
Crossref
Hairong Sun, Feiyan Zhao, Yuanyuan Liu, Teng Ma, Hao Jin, Keyu Quan, Bing Leng, Junwu Zhao, Xiaoling Yuan, Zhenguang Li, Fang Li, Lai-Yu Kwok, Shukun Zhang, Zhihong Sun, Jinbiao Zhang & Heping Zhang. (2022) Probiotics synergized with conventional regimen in managing Parkinson’s disease. npj Parkinson's Disease 8:1.
Crossref
Crossref
Ewa Kowalska, Małgorzata Ziarno, Adam Ekielski & Tomasz Żelaziński. (2022) Materials Used for the Microencapsulation of Probiotic Bacteria in the Food Industry. Molecules 27:10, pages 3321.
Crossref
Crossref
Shruti Shandilya, Sandeep Kumar, Niraj Kumar Jha, Kavindra Kumar Kesari & Janne Ruokolainen. (2022) Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection. Journal of Advanced Research 38, pages 223-244.
Crossref
Crossref
Despoina E. Kiousi, Antonia Z. Kouroutzidou, Konstantinos Neanidis, Dimitrios Matthaios, Aglaia Pappa & Alex Galanis. (2022) Evaluating the Role of Probiotics in the Prevention and Management of Age-Related Diseases. International Journal of Molecular Sciences 23:7, pages 3628.
Crossref
Crossref
Vinod Metta, Valentina Leta, Kandadai Rukmini Mrudula, L. K. Prashanth, Vinay Goyal, Rupam Borgohain, Guy Chung-Faye & K. Ray Chaudhuri. (2021) Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation. Journal of Neurology 269:3, pages 1154-1163.
Crossref
Crossref
Sevag Hamamah, Armin Aghazarian, Anthony Nazaryan, Andras Hajnal & Mihai Covasa. (2022) Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling. Biomedicines 10:2, pages 436.
Crossref
Crossref
Shuai Xiang, Jin-Long Ji, Sha Li, Xi-Peng Cao, Wei Xu, Lan Tan & Chen-Chen Tan. (2022) Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Delaram Safarpour, Kaveh Sharzehi & Ronald F. Pfeiffer. (2022) Gastrointestinal Dysfunction in Parkinson’s Disease. Drugs 82:2, pages 169-197.
Crossref
Crossref
Shokufeh Ghasemian Sorboni, Hanieh Shakeri Moghaddam, Reza Jafarzadeh-Esfehani & Saman Soleimanpour. (2022) A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clinical Microbiology Reviews 35:1.
Crossref
Crossref
Emily M. Klann, Upuli Dissanayake, Anjela Gurrala, Matthew Farrer, Aparna Wagle Shukla, Adolfo Ramirez-Zamora, Volker Mai & Vinata Vedam-Mai. (2022) The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review. Frontiers in Aging Neuroscience 13.
Crossref
Crossref
A. Mohankumar, D. Kalaiselvi, G. Thiruppathi, D. Patteswari, S. Tawata & P. Sundararaj. 2022. Role of Nutrients in Neurological Disorders. Role of Nutrients in Neurological Disorders
17
60
.
G. Divyashri & S. G. Prapulla. 2022. Probiotic Research in Therapeutics. Probiotic Research in Therapeutics
237
254
.
Zakira Naureen, Saima Farooq, Tayyaba Zahoor & Syed Abdullah Gilani. 2022. Microbiome-Gut-Brain Axis. Microbiome-Gut-Brain Axis
383
399
.
Lady Johanna Forero-Rodríguez, Jonathan Josephs-Spaulding, Stefano Flor, Andrés Pinzón & Christoph Kaleta. (2021) Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach. Antioxidants 11:1, pages 71.
Crossref
Crossref
Xiaoting Zhou, Jiachen Lu, Kehong Wei, Jing Wei, Puyuan Tian, Mengyun Yue, Yun Wang, Daojun Hong, Fangjun Li, Bo Wang, Tingtao Chen & Xin Fang. (2021) Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson’s Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota. Oxidative Medicine and Cellular Longevity 2021, pages 1-15.
Crossref
Crossref
Sahar Youssef Al-Okbi, Hoda Bakr Mabrok, Enas Sabry K Al-Siedy, Rasha Salah Mohamed & Asmaa Abdelmohsen Ramadan. (2021) Iron status, immune system, and expression of brain divalent metal transporter 1 and dopamine receptors D1 interrelationship in Parkinson’s disease and the role of grape seed and green coffee bean extracts and quercetin in mitigating the disease in rats. Journal of Herbmed Pharmacology 11:1, pages 63-74.
Crossref
Crossref
Thiago M. C. Pereira, Larissa Z. Côco, Alyne M. M. Ton, Silvana S. Meyrelles, Manuel Campos-Toimil, Bianca P. Campagnaro & Elisardo C. Vasquez. (2021) The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases. Antioxidants 10:11, pages 1845.
Crossref
Crossref
Valentina Leta, K. Ray Chaudhuri, Oliver Milner, Guy Chung-Faye, Vinod Metta, Carmine M. Pariante & Alessandra Borsini. (2021) Neurogenic and anti-inflammatory effects of probiotics in Parkinson’s disease: A systematic review of preclinical and clinical evidence. Brain, Behavior, and Immunity 98, pages 59-73.
Crossref
Crossref
Gabriele Deidda & Manuele Biazzo. (2021) Gut and Brain: Investigating Physiological and Pathological Interactions Between Microbiota and Brain to Gain New Therapeutic Avenues for Brain Diseases. Frontiers in Neuroscience 15.
Crossref
Crossref
Xueling Zhu, Bo Li, Pengcheng Lou, Tingting Dai, Yang Chen, Aoxiang Zhuge, Yin Yuan & Lanjuan Li. (2021) The Relationship Between the Gut Microbiome and Neurodegenerative Diseases. Neuroscience Bulletin 37:10, pages 1510-1522.
Crossref
Crossref
Sara Ayman Moustafa, Shrouk Mohamed, Abdelhameed Dawood, Jihan Azar, Ekramy Elmorsy, Noura A. M. Rizk & Mohamed Salama. (2021) Gut brain axis: an insight into microbiota role in Parkinson’s disease. Metabolic Brain Disease 36:7, pages 1545-1557.
Crossref
Crossref
Shen-Yuan Zheng, Hai-Xia Li, Rui-Chen Xu, Wen-Teng Miao, Ming-Yuan Dai, Song-Tao Ding & Han-Deng Liu. (2021) Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease. Ageing Research Reviews 69, pages 101347.
Crossref
Crossref
Li Yang Tan, Xin Yi Yeo, Han-Gyu Bae, Delia Pei Shan Lee, Roger C. Ho, Jung Eun Kim, Dong-Gyu Jo & Sangyong Jung. (2021) Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases?. Life 11:7, pages 698.
Crossref
Crossref
Chin-Song Lu, Hsiu-Chen Chang, Yi-Hsin Weng, Chiung-Chu Chen, Yi-Shan Kuo & Ying-Chieh Tsai. (2021) The Add-On Effect of Lactobacillus plantarum PS128 in Patients With Parkinson's Disease: A Pilot Study. Frontiers in Nutrition 8.
Crossref
Crossref
Elena Cecilia Rosca, Raluca Tudor, Amalia Cornea & Mihaela Simu. (2021) Parkinson’s Disease in Romania: A Scoping Review. Brain Sciences 11:6, pages 709.
Crossref
Crossref
Yiying Huang, Jinchi Liao, Xu Liu, Yunxiao Zhong, Xiaodong Cai & Ling Long. (2021) Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Marina Lorente-Picón & Ariadna Laguna. (2021) New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota. Biomolecules 11:3, pages 433.
Crossref
Crossref
Marina Boziki, Nikolaos Grigoriadis, Apostolis Papaefthymiou, Michael Doulberis, Stergios A. Polyzos, Emmanuel Gavalas, Georgia Deretzi, Eleni Karafoulidou, Evangelia Kesidou, Charilaos Taloumtzis, Paschalis Theotokis, Electra Sofou, Panagiotis Katsinelos, Elisabeth Vardaka, Ioannis Fludaras, Maria Touloumtzi, Argiro Koukoufiki, Constantina Simeonidou, Christos Liatsos & Jannis Kountouras. (2021) The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis. Neurochemistry International 144, pages 104938.
Crossref
Crossref
Azliza Ibrahim, Raja Affendi Raja Ali, Mohd Rizal Abdul Manaf, Norfazilah Ahmad, Farah Waheeda Tajurruddin, Wong Zhi Qin, Siti Hajar Md Desa & Norlinah Mohamed Ibrahim. (2020) Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson’s disease: A randomised controlled trial. PLOS ONE 15:12, pages e0244680.
Crossref
Crossref
Gazerani. (2019) Probiotics for Parkinson’s Disease. International Journal of Molecular Sciences 20:17, pages 4121.
Crossref
Crossref
Jin Gyu Choi, Eugene Huh, Namkwon Kim, Dong-Hyun Kim & Myung Sook Oh. (2019) High-throughput 16S rRNA gene sequencing reveals that 6-hydroxydopamine affects gut microbial environment. PLOS ONE 14:8, pages e0217194.
Crossref
Crossref
Li-Hao Cheng, Yen-Wenn Liu, Chien-Chen Wu, Sabrina Wang & Ying-Chieh Tsai. (2019) Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders. Journal of Food and Drug Analysis 27:3, pages 632-648.
Crossref
Crossref
Despoina Kiousi, Athanasios Karapetsas, Kyriaki Karolidou, Mihalis Panayiotidis, Aglaia Pappa & Alex Galanis. (2019) Probiotics in Extraintestinal Diseases: Current Trends and New Directions. Nutrients 11:4, pages 788.
Crossref
Crossref
Xin Fang. (2018) Microbial treatment: the potential application for Parkinson’s disease. Neurological Sciences 40:1, pages 51-58.
Crossref
Crossref
Zhange Yu, Shuai Zhang, Dongdong Wang, Meng Fan, Fuqiang Gao, Wei Sun, Zirong Li & Shiliang Li. (2017) The significance of uric acid in the diagnosis and treatment of Parkinson disease. Medicine 96:45, pages e8502.
Crossref
Crossref
Nasibeh Ghalandari, Farhad Assarzadegan, Hossein Mahdavi, Elham Jamshidi & Hadi Esmaily. (2022) Using Probiotics to Alleviate Constipation Symptoms in Parkinson Patients: A Systematic Review and Meta-Analysis. SSRN Electronic Journal.
Crossref
Crossref
Xiaodong Yang, Xiaoqin He, Shaoqing Xu, Yi Zhang, Chengjun Mo, Yiqiu Lai, Yanyan Song, Zheng Yan, Penghui Ai, Yiwei Qian & Qin Xiao. (2022) Effect of <i>Lacticaseibacillus Paracasei</i> Strain Shirota Supplementation on Clinical Responses, Gut Microbiota and Faecal Metabolites in Patients with Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial. SSRN Electronic Journal.
Crossref
Crossref